| 摘要 |
The present invention relates to dibenzodiazepinones of Formula I, thei r pharmaceutically acceptable salts and prodrugs, to methods for obtaining suc h compounds, to pharmaceutical compositions comprising them, and to their use as pharmaceuticals, in particular as inhibitors of cancer, and mammalian lipoxygenase, or as a PBR binding agent. <IMG>
|
